Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2% in the pre market session after the stock extended its positive momentum as the company partnered with DKSH and Chulalongkorn University to launch 'LIFE-SEQ', Asia's first genomic program for precision health.
Shares of electric vehicle pioneer Tesla (NASDAQ:TSLA) jumped 5.9% in the morning session after CEO Elon Musk purchased approximately $1 billion of the company's stock, a move viewed by investors as a significant vote of confidence.
Shares of ride sharing service Lyft (NASDAQ: LYFT)
jumped 4.4% in the morning session after an analyst highlighted the potential benefits of pending legislation in California.
Shares of online community and discussion platform Reddit (NYSE:RDDT) jumped 1.3% in the morning session after Needham raised its price target on the stock to $300 from $215, while maintaining a Buy rating.
Shares of social media management platform Sprout Social (NASDAQ:SPT) jumped 5.2% in the morning session after the company announced a significant integration with the popular online design platform, Canva.
Shares of analog chip manufacturer Texas Instruments (NASDAQ:TXN)
fell 2.7% in the morning session after China launched two investigations targeting the U.S. semiconductor sector, including an anti-dumping probe that specifically named the company.
Shares of online grocery delivery platform Instacart (NASDAQ:CART) jumped 1.3% in the morning session after the company announced a partnership with UK-based supermarket Morrisons to launch its AI-powered smart trolleys, marking the technology's first deployment in the United Kingdom.
Shares of computer processor maker Intel (NASDAQ:INTC)
jumped 4.3% in the morning session after the company lowered its full-year cost outlook upon completing the sale of a majority stake in its Altera programmable chip business.
Shares of fuel cell technology Plug Power (NASDAQ:PLUG) jumped 1.4% in the morning session after BTIG reiterated its Hold rating on the company, with the market focusing on commentary highlighting strong sales momentum.
Shares of technology real estate company Opendoor (NASDAQ:OPEN)
jumped 5.3% in the morning session after the company extended its positive momentum following a major leadership overhaul and a strategic pivot to an artificial intelligence-focused "software-first" strategy.
Shares of medical device company DexCom (NASDAQ:DXCM)
jumped 2.6% in the morning session after the company announced it would present new product features and positive clinical data at the European Association for the Study of Diabetes (EASD) 2025 conference.
Shares of business development company New Mountain Finance (NASDAQ:NMFC) fell 4.2% in the morning session after Bank of America Securities downgraded the stock's rating from "Buy" to "Underperform" and slashed its price target.
Shares of 3D printing company 3D Systems (NYSE:DDD) jumped 2.9% in the morning session after the stock extended the positive momentum as its joint venture, the National Additive Manufacturing and Innovation Company (NAMI), announced a partnership with aerospace giant Lockheed Martin.
Shares of natural food company Hain Celestial (NASDAQ:HAIN)
fell 25% in the morning session after the company reported disappointing second-quarter 2025 results that missed Wall Street expectations.
Shares of beauty supply retailer Sally Beauty (NYSE:SBH) jumped 4.8% in the morning session after an analyst at Canaccord Genuity raised the stock's price target.
Shares of health coverage company Centene (NYSE:CNC)
fell 3% in the morning session after investor concerns continued to weigh on the stock following a significant financial challenge disclosed by the company's CEO last week.
Despite growing anticipation for a shift towards looser monetary policy, the Federal Reserve faces compelling counterarguments against cutting interest rates. A confluence of persistent inflation remaining above target, the specter of tariff-induced price hikes, and increasing concerns about "stagflation" – a challenging economic scenario combining high inflation with stagnant growth – presents
The U.S. labor market is flashing significant warning signs, with recent data revealing a notable deceleration in hiring, a concerning rise in unemployment claims, and substantial downward revisions to previously reported job gains. This weakening economic picture has immediate and profound implications for the broader economy and is now
As the U.S. economy navigates a complex landscape of persistent inflation and a softening labor market, the financial world is holding its breath in anticipation of a pivotal shift in monetary policy. The Federal Reserve is widely expected to initiate a series of interest rate cuts in the latter
The global economic outlook for the second half of 2025 is increasingly shrouded in uncertainty, as a complex interplay of new policy shifts and persistent geopolitical tensions threatens to unleash a period of heightened macroeconomic volatility. Businesses and consumers alike are bracing for potential changes across a spectrum of critical
In a monumental strategic maneuver poised to redefine the landscape of electronic design automation, Synopsys (NASDAQ: SNPS) has finalized its approximately $35 billion acquisition of Ansys (NASDAQ: ANSS). This colossal merger, which officially closed on July 17, 2025, represents a decisive leap for Synopsys beyond its traditional semiconductor design stronghold,
Washington D.C. – September 15, 2025 – The financial world is bracing for a highly anticipated move by the Federal Reserve, with markets pricing in a near-certain 25-basis-point interest rate cut at the upcoming Federal Open Market Committee (FOMC) meeting on September 16-17. This expected shift in monetary policy comes as
As the financial markets brace for an imminent interest rate cut by the Federal Reserve in September 2025, leading investment banks Goldman Sachs and J.P. Morgan are already looking further afield, forecasting a more extensive easing cycle well into 2026. Their collective outlook suggests that the anticipated September reduction
The artificial intelligence (AI) revolution is not just a buzzword; it's a profound strategic pivot for the world's leading technology companies. Giants like Microsoft (NASDAQ: MSFT), Oracle (NYSE: ORCL), and Synopsys (NASDAQ: SNPS) are aggressively integrating AI into their core operations, product development, and long-term growth strategies. This proactive embrace
Oracle Corporation (NYSE: ORCL) is in the midst of a dramatic transformation, aggressively expanding its cloud infrastructure (OCI) and pioneering multi-cloud database strategies. This monumental pivot is driven by the explosive demand for Artificial Intelligence (AI) workloads and solidified by groundbreaking partnerships with leading AI firms like OpenAI and chip
Copenhagen, Denmark – Novo Nordisk (NASDAQ: NVO), the pharmaceutical powerhouse synonymous with diabetes and obesity care, has significantly pared back its full-year sales and profit projections for 2025, sending ripples through the global anti-obesity drug market. Despite robust initial half-year performance and the surging demand for weight-loss medications, the Danish giant
As financial markets brace for potential shifts in monetary policy, investors are keenly focused on the Federal Reserve's next moves. Historically, the initial reduction of the federal funds rate by the central bank has often signaled a turning point for equity markets, frequently paving the way for substantial gains in
The global anti-obesity drug market is experiencing an unprecedented surge, driven by groundbreaking advancements in pharmacotherapy, particularly the advent of highly effective GLP-1 receptor agonists. These revolutionary medications, capable of achieving significant weight loss, are not only transforming the treatment landscape for millions but also igniting a fierce battle among
The Federal Reserve is expected to cut interest rates by at least a quarter percent this week, dropping its federal funds rate to between 4 and 4.25 percent. What will that mean for gold and silver?
BitMine Immersion Technologies Inc (AMEX:BMNR) has amassed over 2.15 million ETH tokens worth approximately $10 billion, cementing its position as the world’
ATyr Pharma's stock dips after Phase 3 trial of efzofitimod misses steroid reduction goal, but shows improvements in lung function and steroid withdrawal rates.
Tempus AI stock is trading marginally lower on Monday. Recent bullish sentiment follows last Thursday's announcement that Tempus AI received 510(k) clearance from the FDA.
Oracle (NYSE: ORCL) stock continues to rise after historic surge fueled by OpenAI's cloud spending. Year-to-date gain of 82% and nearing trillion-dollar club.
